BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Inhibitex is defunct.

Fate: Acquired by BMS 2012, $2.5B


------------------
If you believe any of this information is incorrect, please let us know.